ResMed Inc. (RMD) FY2027 Q1 P&L / Income Statement

Published · Updated Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)

Key Takeaways

  • Americas sales rose $58.67 M, while Residential Care Software fell $11.12 M.
  • Both Sleep and Breathing Health regions grew 8%, with the Americas adding most of the dollars.
  • Americas brought in 59% of total sales this quarter, against 30% for Rest of World.
  • Residential Care Software is the only piece shrinking, down 7% while sales grew 6%.
  • Americas accounts for 66% of Sleep and Breathing Health sales, against 34% from Rest of World.

The Unvarnished Truth

Sleep and Breathing Health's Americas sales supplied 74% of sales growth.

Sleep and Breathing Health's Americas sales supplied 74% of this quarter's net sales growth, a $58.67 M gain out of a $79.23 M total. Residential Care Software fell $11.12 M in the same period, so the total leaned on one region of one business. Even the growth was partly offset by lower life support device sales, which the filing ties to the planned discontinuation of the Astral device. Americas sales of Sleep and Breathing Health rose 8% from a year earlier.

Management's account is about demand: the increase in Americas devices and masks was primarily attributable to increased demand and unit sales. Rest of World grew 8% in constant currency too, which the filing ties partly to device fleet renewals in France. Currency is not the story here, since the filing says movements in international currencies had a negligible impact on Sleep and Breathing Health net revenue. Americas made up 59% of total sales, against 30% for Rest of World.

Put together, the Americas carries the quarter, and its growth rests on demand the filing describes without a single unit count. What it means for a reader is concentration: one region of one business carries most of the growth. Americas sales of $833.42 M are 59% of the company's total, and Rest of World sales of $426.38 M make up 30%. Will the Americas keep carrying the growth, or does its share fall back when the current demand levels off?

Revenue by Business Segment by Geography

Swipe to see the full flow
ResMed Inc. (RMD) FY2027 Q1 P&L / Income StatementIncome statement for 2026-07-01 through 2026-09-30. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUEGROSSOPERATINGPRE-TAXNETSleep and Breathing Health - AmericasSleep and Breathing Health - Rest of WorldResidential Care SoftwareNet revenueGross profitCost of salesIncome from operationsTotal operating expensesTotal operating expensesTotal other income (loss), netIncome before income taxesNet incomeIncome taxesTotal other income (loss), netTotal other income(loss), net$86.17 MIncome before income taxesPretax income$539.16 MNet revenueNet revenue$1.41 BGross profitGross profit$870.57 MIncome from operationsIncome from operations$452.98 MNet incomeNet income$418.41 MSleep and Breathing Health - AmericasSleep and Breathing Health - Americas$833.42 MTotal operating expensesTotal operatingexpenses$417.58 MIncome taxesIncome taxes$120.74 MTotal operating expensesTotal operating expenses$417.58 MSleep and Breathing Health - Rest of WorldSleep and BreathingHealth - Rest of World$426.38 MCost of salesCost of sales$544.25 MResidential Care SoftwareResidential Care Software$155.01 M
Chart details

ResMed Inc. (RMD) FY2027 Q1 P&L / Income Statement

Income statement for 2026-07-01 through 2026-09-30. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net revenue
1,414,814,000 US dollars
Cost of sales
544,247,000 US dollars
Gross profit
870,567,000 US dollars
Total operating expenses
417,583,000 US dollars
Income from operations
452,984,000 US dollars
Total other income (loss), net
86,171,000 US dollars
Income before income taxes
539,155,000 US dollars
Income taxes
120,742,000 US dollars
Net income
418,413,000 US dollars
Residential Care Software
155,012,000 US dollars
Sleep and Breathing Health - Rest of World
426,383,000 US dollars
Sleep and Breathing Health - Americas
833,419,000 US dollars
Total operating expenses
417,583,000 US dollars

Chart connections

  • Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
ResMed Inc. (RMD) FY2027 Q1 Revenue by Business Segment by Geography Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Intelligent Insights for Investors

What is inside the biggest piece of ResMed's sales?

Sleep and Breathing Health is the biggest piece: its products brought in 89% of sales this quarter, and Americas made up 66% of them. Rest of World made up the other 34%.

What drove the change in ResMed's biggest business over the past year?

Mostly Americas: it added $58.67 M of the $90.36 M rise in revenue from Sleep and Breathing Health over the year. That is 65% of the group's growth.

Intelligent Insights for Lenders

How much does ResMed depend on its biggest piece of sales?

Heavily: Sleep and Breathing Health in the Americas brought in 59% of total sales this quarter, against 30% for its Rest of World sales, the next largest. A slowdown in that one region would hit most of the company's sales.

Intelligent Insights for Employees

Which part of sales by region grew fastest over the past year?

Both Sleep and Breathing Health regions grew 8%, against 6% for total sales. Rest of World sales rose $31.69 M, to $426.38 M.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!